Acute Cardiorespiratory Decompensation in a Child with Nephrotic Syndrome with Bronchial Asthma: Is it Exaggeration of Bronchial Asthma?
Received Date: Nov 13, 2015 / Accepted Date: Jan 21, 2016 / Published Date: Jan 28, 2016
Patients with Nephrotic syndrome have increased tendency for thromboembolism. Pulmonary thrombo-embolism is life threatening complication. We report a case of 3 years old patient a known case of Nephrotic syndrome with bronchial asthma who presented with severe respiratory distress requiring ventilatory support. He was diagnosed with massive bilateral pulmonary embolism and treated successfully with thrombolysis.
Keywords: Nephrotic syndrome; Pulmonary embolism
LPA: Left Pulmonary Artery; RPA: Right Pulmonary Artery; MPA: Main Pulmonary Artery
Thromboembolic episodes are one of the most serious complications in patients with Nephrotic syndrome, with an overall incidence of 25%. Thrombosis in both the arterial and venous sides of circulation has been reported. This risk varies with the nature of the underlying disease and seems to be greatest for membranous nephropathy. Other factors, including the level of serum albumin, previous thromboembolic episodes, and a genetically determined predisposition to thrombosis, may also be involved. Pulmonary embolism if occurs can be life threatening if not diagnosed and treated on time. We report a case of 3 years old child a known case of Nephrotic syndrome who presented with this complication.
A 3 years old male child, a known case of Nephrotic syndrome (frequent relapsing, failed on Levamisole) and hyper reactive airway disease, presented in emergency with sudden onset respiratory distress. On examination there was tachycardia (heart rate 150/min), tachypnea with severe respiratory distress (respiratory rate 60/min), with blood pressure of 88/60 mmHg .There was gross tender hepatomegaly (liver 10 cm below right subcostal margin). In view of his clinical condition he was immediately ventilated. As there was previous history of hyper reactive airway disease, 1st possibility for acute deterioration was thought of acute exacerbation of bronchial asthma. Arterial blood gas analysis showed severe metabolic acidosis (PH 7.2, PCO2-43, PO2 78). His kidney function test showed creatinine=0.8 mg/dl, urea=62 mg/dl, Na=122 mmol/l, K=5.3 mmol/l, and urinalysis showed protein 3+. Other laboratory tests showed Hb=10.8 g/dl, total leucocyte counts=19.2×103 /μL (74% neutrophil, 18% lymphocytes and 7% monocytes) and platelets 502×103 /μL. Serum albumin was 1 gm/dl with total protein of 3.6 g/dl. Lipid profiled showed elevated serum triglyceride (223 mg/dl) and total cholesterol (325 mg/dl). Coagulation parameters showed prolonged activated partial thromboplastin time (89 s) and prothrombin time (15 s). As clinical and ABG parameters did not improve, cardiology opinion was taken. Twelve leads Electrocardiogram revealed sinus tachycardia and right heart strain pattern (Figure 1).
With suspicion of pulmonary embolism, echocardiogram (Echo) was done which revealed dilated right atrium and right ventricle (RV), elevated RV pressures (mild tricuspid regurgitation with peak gradient of 70 mmHg); flow in left pulmonary artery was not seen? Complete occlusion of left pulmonary artery (LPA) by thrombus and right ventricular dysfunction. Computed tomography pulmonary angiography was done which confirmed the presence of thrombus in LPA along with occlusion right lower lobe branch of pulmonary artery (Qanadli score 28/40; left 20/20, right 8/20) (Figure2).
With diagnosis of acute pulmonary thromboembolism, immediate thrombolysis was started with tissue plasminogen activator (t-PA) (dose 0.1 mg/kg/h). Repeat CT pulmonary angiography after 12 h of t-PA infusion did not reveal any significant change in LPA flow but right pulmonary artery branch opened completely. Child ventilator requirement also came down. Repeat echocardiography showed improvement in right ventricular function, reduction in pulmonary artery pressure (TR gradient 50 mmHg) but still there was no flow in left pulmonary artery. Repeat thrombolysis was started with higher dose (0.2 mg/kh/h intravenous infusion) but child had bleeding from central venous line site and because of bleeding thrombolysis was stopped. When bleeding stopped, child was started on heparin infusion. Repeat Echocardiography after 24 h revealed further reduction in RV pressures (TR gradient 40 mmHg) and some flow into LPA was visualized. His clinical condition also improved and was extubated after 4 days. He was started on oral anticoagulants overlapped with intravenous heparin.
He was subsequently discharged after 15 days on oral anticoagulation (to maintain INR=2.5). Immediate follow up after 2 weeks revealed normal flow in LPA with normal RV pressures and function (Figure 3).
CT pulmonary angiography repeated 3 months later revealed normal flow in both pulmonary arteries (Figure 4).
Patients with Nephrotic syndrome are at increased risk of thromboembolic complications. The most frequent site of thrombosis is the deep vein and renal vein [1,2]. Incidence of Arterial thrombosis though less common than venous thrombosis but occurs with higher frequency then general population . The pulmonary embolism (PE) is seldom reported in children, and many pulmonary embolisms remain undiagnosed until postmortem examinations are performed. In a retrospective analysis of about 3600 autopsies performed during 25 years, Buck and his colleagues reported that the incidence of PE was 3.7% in the pediatric population . Bergquist pointed out that the mortality of the children with PE was 30% in cases with delayed diagnosis and treatment .
PE is a pathophysiological syndrome of pulmonary circulation disturbance due to lung vascular obstruction by endogenous and exogenous embolus or local thrombus. If hemorrhage and necrosis are present, pulmonary infarction is diagnosed. The occurrence of PE is related to sludge of blood flow, hypercoagulable status and impaired endothelial cells. Underlying mechanism for increased risk could be the result of impaired thrombolytic activity, imbalance between prothrombotic and antithrombotic factors, hypovolemia. Thromboembolic complications in Nephrotic syndrome take account of increased coagulation factors VIII and fibrinogen, increased platelet adhesiveness, reduced anticoagulation factors such as anti-thrombin III, protein C and protein S levels and their activity, decreasing profibrinolysin, increasing platelet counts, aggregation, attachment and releasing platelet alpha granules, with therapy of diuretics and corticosteroid [2,6].
The clinical presentations of PE are related to the speed of PE developing, the degree of vascular obstruction, the liberated vasoactive amines and the primary cardiopulmonary function status. The vascular obstruction is the most important factor. In the situation of small range of obstruction, few cardio dynamic and pulmonary functional changes are accompanied. An increased pulmonary artery pressure would not happen until 60% pulmonary vascular bed is occluded. Cyanosis and dyspnea generally occur when there is 65% obstruction. Severe pulmonary hypertension and shock will occur at 70%-80% obstruction, and death occurs at greater than 85% occlusion . It should always be suspected in any patient with Nephrotic syndrome presenting with respiratory distress. The use of V/Q scanning to screen asymptomatic children with Nephrotic syndrome has demonstrated changes consistent with PE in 27.9–40% [8,9].
Thrombolysis is an established treatment for adults with PE associated with hemodynamic instability . No clear guidelines exist for the use of thrombolytic therapy in children with PE. Major complication of systemic thrombolysis is bleeding quoted at 37% . The indication for thrombolysis is most frequently cardiorespiratory distress or collapse, suggesting a poor risk group may account for the higher rate of major bleeding.
Children with Nephrotic syndrome and very low serum albumin are at very high risk for thromboembolism. A high index of suspicion is needed by the physician as many of these thrombi are asymptomatic at presentation but can lead to potentially life-threatening complications. In stage of acute deterioration in these patients, pulmonary embolism should be suspected and managed aggressively. Pulmonary embolism carries very high mortality if not treated on time.
- Llach F (1985) Hypercoagulability, Renal Vein Thrombosis, and Other Thrombotic Complications of NephroticSyndrome. Kidney Int 28: 429.
- Singhal R, Brimble KS (2006) Thromboembolic Complications of NephroticSyndrome: Pathophysiology and Clinical Management. Thromb Res 118: 397.
- Mahmoodi BK, Ten Kate MK, Waanders F, Veeger NJ, Brouwer JL,et al. (2008) High Absolute Risk and Predictors of Venous and Arterial Thromboembolic Events in Patients with Nephritic Syndrome: Results from Large Retrospective CohartStudy. Circulation 117: 224.
- Buck JR, Connors RH, Coon WW, Buck JR, Weintraub WH, Wesley JR, et al.(1981) Pulmonary Embolism in Children. J Pediatr Surg 16: 385-391.
- Bergquist D, Lindblad B (1985) A 30-year Survey of Pulmonary Embolism Verified at Autopsy: An Analysis of 1274 Surgical Patients. Br J Surg 72: 105-108.
- Cameron JS (1984) Coagulation and Thromboembolic Complications in the Nephritic Syndrome. AdvNephrol Necker Hosp 13: 75-114.
- Evans DA, Wilmott RW (1994) Pulmonary Embolism in Children. Pediatr Clin North Am 41: 569-584.
- Hoyer PF, Gonda S, Barthels M, Krohn HP, Brodehl J (1986) Thromboembolic Complications in Children with NephroticSyndrome. ActaPaediatrScand 75: 804-810.
- Huang J, Yang J, Ding J (2000) Pulmonary Embolism Associated with NephroticSyndrome in Children: APreliminary Report of 8 Cases. Chinese MedJ 113: 251–253.
- Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, et al. (2004) Antithrombotic Therapy for Venous Thromboembolic Disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126: 401S–428S.
- Gupta AA, Leaker M, Andrew M, Massicotte P, Liu L, et al. (2001) Safety and Outcomes of Thrombolysis with Tissue Plasminogen Activator for Treatment of Intravascular Thrombosis in Children. Journal of Pediatr139: 682–688.
Citation: Tomar M, Azad S, Sethi S (2016) Acute Cardiorespiratory Decompensation in a Child with Nephrotic syndrome with Bronchial Asthma: Is it Exaggeration of Bronchial Asthma?. Clin Pediatr 1: 104. Doi: 10.4172/2572-0775.1000104
Copyright: ©2016 Tomar M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
16th Annual World Congress on Pediatrics
March 21-22, New York, USA
World Neonatology Meeting June 04-05, 2018 Prague, Czech Republic
June 4-5, 2018 Osaka, Japan
4th International Conference on Clinical Pediatrics
June 14-16, 2018 Rome, Italy
17th Annual Congress on Pediatrics & Adolescent Medicine
July 09-10, 2018 Sydney, Australia
1st Global Summit on Pediatrics, Neonatology & Primary Care July 16-17, 2018 Dubai, UAE
July 16-17, 2018 Atlanta, USA
3rd International Conference on Pediatric Neurology, November 12-13, 2018 Lisbon, Portugal
September 19-20, 2018 Macau, Hong Kong
12th World Pediatric Congress, December 10-12, 2018, Abudhabi
September 19-20, 2018 Macau, Hong Kong
- Total views: 8430
- [From(publication date): 4-2016 - Mar 20, 2018]
- Breakdown by view type
- HTML page views: 8349
- PDF downloads: 81